SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-097648
Filing Date
2023-09-01
Accepted
2023-09-01 13:38:30
Documents
6
Period of Report
2023-09-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2325301d1_pre14a.htm PRE 14A 507617
2 GRAPHIC tm2325301d1_pre14aimg001.jpg GRAPHIC 4145
3 GRAPHIC tm2325301d1_pre14aimg002a.jpg GRAPHIC 96942
4 GRAPHIC tm2325301d1_pre14aimg003a.jpg GRAPHIC 80792
5 GRAPHIC tmb-20230831xcoverg001.jpg GRAPHIC 235002
6 GRAPHIC tmb-20230831xcoverg002.jpg GRAPHIC 157092
  Complete submission text file 0001104659-23-097648.txt   1300122
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: PRE 14A | Act: 34 | File No.: 001-37846 | Film No.: 231231890
SIC: 3841 Surgical & Medical Instruments & Apparatus